Cited by 1,855Pregnancy and preeclampsia studiesNeurological Complications and SyndromesTGF-β signaling in diseases

Soluble endoglin contributes to the pathogenesis of preeclampsia

Venkatesha, Shivalingappa, Toporsian, Mourad, Lam, Chun, Hanai, Jun-ichi, Mammoto, Tadanori, Kim, Yeon M, Bdolah, Yuval, Lim, Kee-Hak +11 more·2006·Nature Medicine

Abstract

Preeclampsia is a pregnancy-specific hypertensive syndrome that causes substantial maternal and fetal morbidity and mortality. Maternal endothelial dysfunction mediated by excess placenta-derived soluble VEGF receptor 1 (sVEGFR1 or sFlt1) is emerging as a prominent component in disease pathogenesis. We report a novel placenta-derived soluble TGF-beta coreceptor, endoglin (sEng), which is elevated in the sera of preeclamptic individuals, correlates with disease severity and falls after delivery. sEng inhibits formation of capillary tubes in vitro and induces vascular permeability and hypertension in vivo. Its effects in pregnant rats are amplified by coadministration of sFlt1, leading to severe preeclampsia including the HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome and restriction of fetal growth. sEng impairs binding of TGF-beta1 to its receptors and downstream signaling including effects on activation of eNOS and vasodilation, suggesting that sEng leads to dysregulated TGF-beta signaling in the vasculature. Our results suggest that sEng may act in concert with sFlt1 to induce severe preeclampsia.

Integrity signals

Registry

Crossref · 10.1038/nm1429

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Venkatesha, S., Toporsian, M., Lam, C., Hanai, J.-I., Mammoto, T., Kim, Y. M., Bdolah, Y., Lim, K.-H., Yuan, H.-T., Libermann, T. A., Stillman, I. E., Roberts, D., D'Amore, P. A., Epstein, F. H., Sellke, F. W., Romero, R., Sukhatme, V. P., Letarte, M., & Karumanchi, S. A.
Affiliations
  • Beth Israel Deaconess Medical Center (US)
  • University of Toronto (CA)
  • National Institutes of Health (US)
  • Harvard University (US)
Corresponding author
Karumanchi, S Ananth
Venue
Nature Medicine
Published
2006-06-01
Volume
12
Issue
6
Pages
642-649
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2105632053
Cited by
1,855
References
51
Citations by year
2026: 45 · 2025: 48 · 2024: 49 · 2023: 68 · 2022: 88 · 2021: 106 · 2020: 80 · 2019: 88 · 2018: 99 · 2017: 113 · 2016: 92 · 2015: 97 · 2014: 102 · 2013: 101 · 2012: 130
FWCI
126.42
Type
journal article
Language
en
Update notices
erratum (2006-07-01)
Open access
closed
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Heart and Stroke Foundation of Canada
  • National Institutes of Health (1r03dk064255-01)
  • National Heart, Lung, and Blood Institute (HL 079594, R01HL079594)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK064255)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Neurological Complications and Syndromes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
preeclampsia, soluble endoglin, soluble VEGF receptor-1, soluble fms-like tyrosine kinase-1, TGF-beta signaling, endothelial dysfunction, placenta, HELLP syndrome, fetal growth restriction, vascular permeability, hypertension, endothelial nitric oxide synthase, vasodilation, pathogenesis
MeSH terms
Endoglin, Adult, Amino Acid Sequence, Animals, Female, Gestational Age, Hemodynamics, Humans, Kidney, Liver, Middle Aged, Molecular Sequence Data, Placenta, Pre-Eclampsia, Pregnancy, Pregnancy, Animal, Receptors, Cell Surface, Signal Transduction, Antigens, CD, Transforming Growth Factor beta, Rats, Sprague-Dawley, Mice, Knockout, Vascular Endothelial Growth Factor Receptor-1, Endothelial Cells, Mice, Rats, Nitric Oxide Synthase Type III, Transforming Growth Factor beta1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review